Help us make trastuzumab deruxtecan available to more breast cancer patients
Categories: Personal Diagnosis, HER2-low
Help us reverse NICE’s provisional rejection of the drug trastuzumab deruxtecan for certain breast cancer patients by sharing why you think it should be made available.
What’s the project about?
The drug trastuzumab deruxtecan (Enhertu) is already available on the NHS for certain patients with secondary breast cancer, but it could potentially benefit even more patients. It’s the first treatment licensed for HER2-low breast cancer.
It’s been provisionally rejected by NICE for use on the NHS in England for treating HER2-low secondary breast cancer, and breast cancer that can’t be removed by surgery. However, this decision isn’t final, and there’s a chance to reverse it.
There’s a period of consultation about this provisional rejection until 5pm on 17 October. The NICE Committee will then reconsider this treatment.
You can help us take action to reverse this decision by sharing why you feel having this treatment option would be important.
Who can take part?
We want to hear from people who may have HER2-low secondary breast cancer or have experience of trastuzumab deruxtecan for treating HER2-low breast cancer.
This is a new way of classifying breast cancer, so if you don’t know what it means, you can read more on our website.
Why do you want me to be involved?
By sharing your views on why this drug should be made available on the NHS in England, you can help us strengthen our response to the NICE consultation. This can help reverse this decision and make trastuzumab deruxtecan available to more patients.
What will you ask me to do?
You can share your feedback with us to add to our response. Anything you share with us will be used anonymously. Or, you can respond directly to the NICE consultation.
To add to our contribution, please email the policy team at policy@breastcancernow.org. You can share your breast cancer story with us, and why you think that having this drug available to patients is important.
To respond directly to NICE, you can add your contribution on their website.
How do I get involved?
Please email us at policy@breastcancernow.org with your views.
Or, you can respond directly to NICE.
Share your voice
This opportunity has expired. You can check out our Share your voice page for more ways to get involved.